EXAGEN INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Exagen Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q2 2024.
  • Exagen Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 18.2M shares, a 2.96% increase year-over-year.
  • Exagen Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 17.7M shares, a 3.5% increase from 2022.
  • Exagen Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 17.1M shares, a 6.95% increase from 2021.
  • Exagen Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 16M shares, a 26.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 18.2M +523K +2.96% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 17.9M +418K +2.38% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 17.7M +597K +3.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 17.7M +612K +3.58% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 17.7M +597K +3.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 17.5M +534K +3.15% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 17.1M +1.11M +6.95% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 17.1M +135K +0.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 17.1M +130K +0.77% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 17M +4.05M +31.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 16M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 16.9M +4.3M +34% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 16.9M +4.29M +34% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-21
Q1 2021 12.9M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 12.6M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 12.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.